BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 1465843)

  • 21. Effect of dithiothreitol on a variety of evolutive patterns of anti-T and -B lymphocyte antibodies in renal transplant candidates.
    García de Masdevall MD; Arrieta A; Riñón M; Altés C; Arranz C
    Transplant Proc; 1992 Dec; 24(6):2505-7. PubMed ID: 1465847
    [No Abstract]   [Full Text] [Related]  

  • 22. Relevant factors affecting the likelihood of retransplantation following kidney graft failure.
    Etienne T; Ruedin P; Leski M
    Transplant Proc; 1992 Dec; 24(6):2767-8. PubMed ID: 1465934
    [No Abstract]   [Full Text] [Related]  

  • 23. Renal transplantation in highly sensitised recipients.
    Klouda PT; Rogers CA; Corbin SA; Bradley BA
    Transplant Proc; 1990 Aug; 22(4):1903. PubMed ID: 2202132
    [No Abstract]   [Full Text] [Related]  

  • 24. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beneficial effect of DR matching on cadaveric renal graft survival in Scandiatransplant.
    Leivestad T; Berger L; Thorsby E
    Transplant Proc; 1992 Dec; 24(6):2447-8. PubMed ID: 1465824
    [No Abstract]   [Full Text] [Related]  

  • 26. Importance of certain HLA-A,B haplotypes for the survival of renal grafts from living-related donors.
    Polymenidis Z; Adam K; Parapanissiou E; Sakellariou G; Papakyriazi E; Antoniadis A; Papadimitriou M
    Transplant Proc; 1992 Dec; 24(6):2458-60. PubMed ID: 1465830
    [No Abstract]   [Full Text] [Related]  

  • 27. Soluble HLA and anti-idiotypic antibodies in transplantation: modulation of anti-HLA antibodies by soluble HLA antigens from the graft and anti-idiotypic antibodies in renal and cardiac allograft recipients.
    Suciu-Foca N; Ho E; King DW; Yu YP; Yu-Kai S; Reed E; Cohen D; Brensilver JM; McCabe R; Rose E
    Transplant Proc; 1991 Feb; 23(1 Pt 1):295-6. PubMed ID: 1990536
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of anti-HLA antibodies on the long-term survival of heart and kidney allografts.
    Barr ML; Cohen DJ; Benvenisty AI; Hardy M; Reemtsma K; Rose EA; Marboe CC; D'Agati V; Suciu-Foca N; Reed E
    Transplant Proc; 1993 Feb; 25(1 Pt 1):262-4. PubMed ID: 8438294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Six-year experience with a triple drug protocol in renal transplantation: analysis of risk factors.
    Pallardó LM; Sánchez P; Sánchez J; García J; Orero E; Beneyto I; Cruz JM
    Transplant Proc; 1992 Dec; 24(6):2714-5. PubMed ID: 1465911
    [No Abstract]   [Full Text] [Related]  

  • 30. Influence of pretransplant antibodies on early renal allograft rejection.
    Alarif L; Rodriguez R; Blackburn S; Light JA
    Transplant Proc; 1987 Feb; 19(1 Pt 1):771-2. PubMed ID: 3274869
    [No Abstract]   [Full Text] [Related]  

  • 31. HLA typing on peripheral blood lymphocytes from cadaveric donors to reduce cold ischemia.
    Muñoz C; Franco A; Prados MC; de la Sen ML; Perdiguero M; Olivares J
    Transplant Proc; 1992 Dec; 24(6):2490-1. PubMed ID: 1465840
    [No Abstract]   [Full Text] [Related]  

  • 32. Flow cytometric measurements in 104 anti-T-lymphocyte globulin treatments.
    Ekberg H; Persson NH; Olsson M; Lundell A; Bredberg A
    Transplant Proc; 1992 Dec; 24(6):2551-2. PubMed ID: 1465863
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-dose triple immunosuppression for HLA identical sibling kidney transplants.
    Schweizer RT; Roper L; Hull D; Bartus SA
    Transplant Proc; 1992 Dec; 24(6):2609. PubMed ID: 1465882
    [No Abstract]   [Full Text] [Related]  

  • 35. Kidney transplantation in Slovenia from 1986 through 1991.
    Kandus A; Buturović-Ponikvar J; Malovrh M; Bren AF
    Transplant Proc; 1992 Dec; 24(6):2430-1. PubMed ID: 1465818
    [No Abstract]   [Full Text] [Related]  

  • 36. Combined liver and kidney transplantation in a highly sensitized and positively cross-matched patient.
    Alqurashi S; Alsayyari AA; Abdullah K; Alwan A; Hajeer AH
    Saudi J Kidney Dis Transpl; 2011 Jul; 22(4):757-60. PubMed ID: 21743223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect on sensitisation of giving HLA-DR-matched blood to potential renal transplant recipients.
    Middleton D; Martin J; Magee BA; Douglas JF
    Transplant Proc; 1992 Dec; 24(6):2535-6. PubMed ID: 1465857
    [No Abstract]   [Full Text] [Related]  

  • 39. [Incidence of anti-HL-A antibodies in patients under dialysis and in a transplantation program in relation to rejection].
    Erbenová E; Erben J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1976; 19(3):303-9. PubMed ID: 801077
    [No Abstract]   [Full Text] [Related]  

  • 40. Crossmatch with donor skin: its correlation with early rejection of kidney transplants.
    Lasmar E; Távora E; Salomão A; Bambirra E; Penafiel P; Vilaça S
    Transplant Proc; 1992 Dec; 24(6):3070-1. PubMed ID: 1466059
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.